title: Pragmatic Trials for Noncommunicable Diseases: Relieving Constraints.
abstract: In this month's editorial, PLOS Medicine Editorial Board member Anushka Patel and Ruth Webster discuss how applying rules for drug efficacy trials can impede pragmatic trials of interventions for noncommunicable diseases.
authors.affiliation: The George Institute for Global Health, University of Sydney, Sydney, Australia.
authors.forename: Anushka
authors.initials: A
authors.lastname: Patel
authors.affiliation: The George Institute for Global Health, University of Sydney, Sydney, Australia.
authors.forename: Ruth
authors.initials: R
authors.lastname: Webster
mesh_terms: D000428:Alcohol Drinking / Q000628:therapy; D003920:Diabetes Mellitus / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000628:therapy; D009765:Obesity / Q000628:therapy; D064792:Pragmatic Clinical Trials as Topic; D012106:Research; D012107:Research Design; D057185:Sedentary Behavior; D064424:Tobacco Use / Q000628:therapy; D057170:Translational Research, Biomedical; D014944:World Health Organization